MediGene AGMediGene AGMediGene AG

MediGene AG

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪699.78 K‬USD
‪14.46 M‬
Beta (1Y)
2.63

About MediGene AG


CEO
Ralph Schaefer
Headquarters
Martinsried
Founded
1996
IPO date
Jun 30, 2000
Identifiers
2
ISIN DE000A40ESG2
MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. It focuses on the development of personalized T-cell based immunotherapies. It operates through the Immunotherapies and Other products segments. The company was founded by Ernst Ludwig Winnacker and Horst Domdey in June 1994 and is headquartered in Martinsried, Germany.

Check out other big names from the same industry as MDGEF.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MDGEF is 0.1000 USD — it has decreased by −96.14% in the past 24 hours. Watch MediGene AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange MediGene AG stocks are traded under the ticker MDGEF.
MDGEF reached its all-time high on Jan 3, 2001 with the price of 104.0000 USD, and its all-time low was 0.1000 USD and was reached on May 14, 2025. View more price dynamics on MDGEF chart.
See other stocks reaching their highest and lowest prices.
MDGEF stock is ‪2.49 K‬% volatile and has beta coefficient of 2.63. Track MediGene AG stock price on the chart and check out the list of the most volatile stocks — is MediGene AG there?
Today MediGene AG has the market capitalization of ‪699.78 K‬, it has increased by 66.94% over the last week.
Yes, you can track MediGene AG financials in yearly and quarterly reports right on TradingView.
MediGene AG is going to release the next earnings report on Mar 26, 2026. Keep track of upcoming events with our Earnings Calendar.
No, MDGEF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MDGEF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MediGene AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MediGene AG technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MediGene AG stock shows the strong sell signal. See more of MediGene AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.